CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-25 | Kelly Timothy P Chief Technology Officer | Sale | −6,228 | $1.93 | $12K | 73,125 |
| 2026-02-24 | Albertson Tina M. Chief Medical Officer | Sale 10b5-1 | −1,066 | $1.96 | $2K | 68,523 |
| 2026-02-24 | Khan Ruhi Ahmad Chief Business Officer | Sale | −6,938 | $1.96 | $14K | 104,998 |
| 2026-02-24 | Kelly Timothy P Chief Technology Officer | Sale | −3,147 | $1.96 | $6K | 79,353 |
| 2026-02-24 | MCCLUNG BARBARA G Chief Legal Officer | Sale | −6,938 | $1.96 | $14K | 481,564 |
| 2026-02-20 | Albertson Tina M. Chief Medical Officer | Grant or award 10b5-1 | +55,000 | 69,589 | ||
| 2026-02-20 | Albertson Tina M. Chief Medical Officer | Grant or award · Option to purchase Common Stock 10b5-1 | +247,500 | 247,500 | ||
| 2026-02-20 | Khan Ruhi Ahmad Chief Business Officer | Grant or award | +45,000 | 111,936 | ||
| 2026-02-20 | Khan Ruhi Ahmad Chief Business Officer | Grant or award · Option to purchase Common Stock | +202,500 | 202,500 | ||
| 2026-02-20 | Kelly Timothy P Chief Technology Officer | Grant or award | +45,000 | 82,500 | ||
| 2026-02-20 | Kelly Timothy P Chief Technology Officer | Grant or award · Option to purchase Common Stock | +202,500 | 202,500 | ||
| 2026-02-20 | MCCLUNG BARBARA G Chief Legal Officer | Grant or award | +45,000 | 488,502 | ||
| 2026-02-20 | MCCLUNG BARBARA G Chief Legal Officer | Grant or award · Option to purchase Common Stock | +202,500 | 202,500 | ||
| 2026-02-20 | Richardson-Heron Dara Director | Grant or award · Option to purchase Common Stock | +45,000 | 45,000 | ||
| 2026-02-20 | Zheng Ran Director | Grant or award · Option to purchase Common Stock | +45,000 | 45,000 | ||
| 2026-02-20 | Whiting Nancy Director | Grant or award · Option to purchase Common Stock | +45,000 | 45,000 | ||
| 2026-02-20 | Ryali Sriram Chief Financial Officer | Grant or award | +55,000 | 72,360 | ||
| 2026-02-20 | Ryali Sriram Chief Financial Officer | Grant or award · Option to purchase Common Stock | +247,500 | 247,500 | ||
| 2026-02-20 | JOHNSON DAVID LEE Director | Grant or award · Option to purchase Common Stock | +45,000 | 45,000 | ||
| 2026-02-20 | Sacks Natalie Director | Grant or award · Option to purchase Common Stock | +45,000 | 45,000 |
Page 1 of 9 · 177 trades